Jpmorgan Chase & CO Yumanity Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.1 Trillion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$0.97 - $3.27 $2,856 - $9,630
-2,945 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$2.81 - $10.48 $8,275 - $30,863
2,945 New
2,945 $9,000

Others Institutions Holding YMTX

# of Institutions
1
Shares Held
7
Call Options Held
0
Put Options Held
0
View Full List

About YUMANITY THERAPEUTICS, INC.

YMTX Quotes by TradingView
  • Ticker YMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,856,500
  • Description
  • Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...
More about YMTX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email